(Q37863881)

24 August 2017

title

CpG motifs as adjuvant in DNA vaccination against Chlamydophila psittaci in turkeys (English)

1 reference

24 August 2017

1 reference

Chlamydophila psittaci

object named as

Chlamydophila psittaci

1 reference

Bruno Maria Goddeeris

4

0 references

author name string

Karolien Loots

1

1 reference

24 August 2017

Marnix Van Loock

2

1 reference

24 August 2017

Daisy Vanrompay

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

22 August 2005

1 reference

24 August 2017

1 reference

24 August 2017

volume

24

1 reference

24 August 2017

issue

21

1 reference

24 August 2017

page(s)

4598-4601

1 reference

The prevalence of Chlamydia psittaci infections in Belgian commercial turkey poults

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.042

10.1016/J.VACCINE.2005.08.042

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference